Abstract:BACKGROUND & OBJECTIVE:Studies have revealed that overexpression of p53 protein has close relation to induction of drug resistance in cancer patients and it can be used as a predictor for chemosensitivity of tumor. Recently, it has been found that specific p53 antibody (p53-Ab) presented in the serum of cancer patients with p53 protein overexpression. Furthermore, the presence of serum p53-Ab is closely correlated with p53 protein overexpression. Thus, serum p53-Ab could theoretically be useful in predicting chemosensitivity in cancer patients. In the present study, we investigated whether preoperative serum p53-Ab is correlated with the postoperative chemosensitivity of esophageal cancer, which was analyzed using in vitro drug response assay.METHOD:Serum analysis of p53 antibodies was performed by enzyme-linked immunosorbent assay (ELISA) in 38 patients with esophageal cancer preoperatively, then surgically resected specimens were analyzed for their chemosensitivity to cisdichlorodiammineplatinum (DDP),5-fluorouracil (5-FU), and Adriamycin (ADM) by in vitro drug response assay MTT colorimetry.RESULTS:Serum p53-Ab was present in 47.3% of the patients with esophageal cancer. The positive rate of serum p53-Abs in patients was significantly different from that in healthy blood donors (P< 0.01). The positive rate of serum p53-Ab was 25%(5/20) for the patients at stage I and II, and 72.2%(13/18) for the patients at stage III and IV.A significant correlation between serum p53-Ab positive rate and TNM stage was observed (P< 0.05). The positive rate of serum p53-Ab were 21.5%(3/14), 50%(6/12), 75% (9/12) for the patients with well, moderately,and poorly differentiated tumors, respectively. There was significant correlation between serum p53-Ab positive rate and tumor differentiation (P< 0.05). The chemosensitivity to DDP, 5-FU, and ADM (11.1%,16.1%,and 16.1%, respectively) of the patients with positive serum p53-Ab was significantly lower than that of the patients with negative p53-Ab (60%, 45%, and 35%; P< 0.01,P< 0.05, and P< 0.05, respectively).CONCLUSION:p53-Ab is not only a prognostic marker for patients with esophageal cancer, but also a predictor of their response to chemotherapy.

[Correlation Between Serum P53 Antibody and Chemosensitivity in Patient with Esophageal Cancer].

The Potential for Serum P53 to Predict the Response to Chemotherapy of Patients with Gastric Cancer

Relationship Between the P53 Functional Status of Human Tumor Cell Lines and Their Chemosensitivities to Different Anticancer Drug

Expression of MDR1mRNA detected and its correlation with p53 in esophageal carcinoma by in situ hybridization

Correlation of P53 protein expression in epithelial ovarian and chemotherapy sensitivity

Correlation of P53 Status with the Response to Chemotherapy-Based Treatment in Esophageal Cancer: A Meta-Analysis

Clinical Significance of P53 Expression in Colorectal Cancer Patients

The clinical significance of p53 and pRb signal pathway in esophageal cancer patients

Correlation between p53 mutations and chemosensitivity in colorectal carcinoma cells

Relation between preoperative chemotherapy and expression of p27 and Ki67 in tissues of esophageal carcinoma

Elevated P53 Expression Levels Correlate with Tumor Progression and Poor Prognosis in Patients Exhibiting Esophageal Squamous Cell Carcinoma.

Circulating p53 antibody in patients with colorectal cancer: relation to clinicopathologic features and survival

Correlation between p53 expression in breast cancer and clinical response to neoadjuvant chemotherapy: a Meta-analysis

Relationship with tissue differentiation and postoperative dynamic change of serum p53 antibody level in patients with esophageal squamous cell carcinoma

The Expression and Importance of P53 Protein in Colorectal Carcinoma

The Presence of Serum Anti-p53 Antibodies from Patients with Invasive Ductal Carcinoma of Breast: Correlation to Other Clinical and Biological Parameters

Overexpression of P53 Gene in Esophageal and Cer-vical Cancer and the Relationship with Radiothera-py Effects

Characterization and correlation of 14-3-3σ and P53 protein expressions in multi-stage carcinogenesis of esophageal squamous cell carcinoma

Overexpression of P53 Gene in Esophageal and Cervical Cancer and the Relationship with Radiotherapy Effects

The relation between the chemotherapeutic efficacy and p53, P-glycoprotein and survival time in patients with gastric cancer

P53immunostaining Positive Cells Correlated Positively with S Phase Cells As Measured by BrdU in the Esophageal Precancerous Lesions from the Subjects at High Incidence Area for Esophageal Cancer in Northern China